Clinical Trial Detail

NCT ID NCT03563157
Title QUILT 3.071: NANT Colorectal Cancer (CRC) Vaccine
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements yes
Sponsors NantKwest, Inc.
Indications

colorectal cancer

Therapies

NANT colorectal cancer vaccine combination

Regorafenib

Age Groups: adult senior

Additional content available in CKB BOOST